Consecutive Treatment for Pulmonary Arterial Hypertension: Practice Limit under Objective
Received Date: Nov 02, 2022 / Published Date: Nov 30, 2022
Abstract
In pulmonary arterial hypertension (PAH), little is known about the effects of consecutive mix treatment on practice limit. Through cardiopulmonary exercise testing (CPX), we determined that using a maximum oxygen take-up (VO2) cutoff of 15 mL/min/kg for direct blend treatment was advantageous. The patients underwent CPX at pattern, 3, 6, and one year. Practice limit logically worked on in patients who were recently diagnosed with PAH because successive mix treatment was overhauled by patients' highest VO2. As a result, a rerun of the CPX evaluation can provide useful information regarding the suitability of objectively planned treatment for PAH.
Citation: Patel P (2022) Consecutive Treatment for Pulmonary Arterial Hypertension: Practice Limit under Objective. J Card Pulm Rehabi 6: 178. Doi: 10.4172/jcpr.1000178
Copyright: © 2022 Patel P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 1334
- [From(publication date): 0-2022 - May 20, 2024]
- Breakdown by view type
- HTML page views: 1140
- PDF downloads: 194
